MAPT and Alzheimer disease: For example, the MOMs study (Modification of Maternal AD risk in DS) is designed to more closely examine family history of dementia and other parental biomarkers (e.g., plasma amyloid and tau levels) and parental genetic profiles that might have an impact on the emergence of early signs of dementia among ABC‐DS participants.